Advertisements

Мигренол

Quick links to important sections

Мигренол

Advertisements

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Мигренол

Property Description
Active Ingredient Acetaminophen and Caffeine
Form Tablet (Oral administration)
Pharmacological Class Non-opioid Analgesic Combination
General Purpose Symptomatic relief of pain and fever
Origin Synthetic Compounds

Мигренол is defined as an oral, fixed-dose combination analgesic, a proprietary pharmaceutical preparation supplied as a tablet. This medicine belongs to the non-opioid analgesic pharmacological class and utilizes two distinct, synthetic compounds: Acetaminophen (Paracetamol) and Caffeine (a methylxanthine derivative). The formulation is generally available as an Over-The-Counter (OTC) medicine, specifically positioned for the symptomatic management of acute pain syndromes, such as common tension headaches.

The general therapeutic purpose of the drug is dual: to achieve symptomatic relief for pain and to reduce fever. The primary function of the Acetaminophen component is to act centrally, helping to elevate the body’s pain threshold and lower the perception of discomfort. The role of Caffeine is clinically recognized for acting as an adjuvant, significantly enhancing the pain-relieving efficacy of the primary analgesic agent.

This combined formulation is the core differentiating factor from single-ingredient pain relievers. The synergistic effect ensures a more potent analgesic response compared to taking Acetaminophen alone. The preparation is thus designed to offer dual-action relief—pain-modulating and efficacy-boosting—making it a recognized option for individuals seeking efficient relief from widespread acute discomfort.

Advertisements

What side effects are possible with Мигренол?

Possible Side Effects and Safety Information: Мигренол

Мигренол (a combination product typically containing Acetaminophen, Caffeine, and Diphenhydramine) is generally well-tolerated when used as directed, but it is important to be aware of potential side effects and safety concerns.


Common Side Effects

Side effects related to the antihistamine component (Diphenhydramine) may include drowsiness, dizziness, dry mouth, and constipation. The stimulant component (Caffeine) may cause nervousness, restlessness, or trouble sleeping (insomnia). Gastrointestinal upset such as nausea or stomach pain can also occur.


Serious Warnings and Precautions

Liver Damage

Мигренол contains acetaminophen. Severe liver damage may occur if the maximum daily dose is exceeded, if taken with other acetaminophen-containing products, or if three or more alcoholic drinks are consumed daily while using this medicine. Symptoms of liver toxicity can include nausea, vomiting, loss of appetite, dark urine, and yellowing of the skin or eyes (jaundice). Immediate medical attention is necessary if an overdose is suspected, even if symptoms are absent.

Allergic Reactions and Cardiovascular Risk

Rare but serious allergic reactions may manifest as rash, itching, swelling of the face, throat, or tongue, and severe dizziness or trouble breathing. Additionally, due to the caffeine content, the medicine should be used with caution in individuals with certain heart conditions, as it may cause an irregular or fast heartbeat.


Contraindications and Interactions

This medicine should not be taken with other products containing acetaminophen, other antihistamines (including topical diphenhydramine), or MAO inhibitors. Use should be avoided in patients with severe liver disease, narrow-angle glaucoma, or severe breathing problems (like severe asthma or COPD). Due to the drowsiness caused by diphenhydramine, caution is advised when operating machinery or driving. Consult a healthcare professional about your medical history and all current medications before use.

Advertisements

Overdose and Emergency Response

Overdose and when to Seek Help: Official Regulatory Information

This section provides information documented in official government regulatory sources regarding Мигренол overdose.

Documented Overdose Manifestations

Initial manifestations of overdose frequently include Nausea, Vomiting, Abdominal Pain, and Anorexia. The critical risk is the delayed onset of Hepatotoxicity (severe liver damage), where clinical signs like Jaundice may not appear until 24 to 96 hours post-ingestion. High doses may also lead to Tachycardia, Seizures, and Irregular Heartbeat due to the caffeine component.

Life-Threatening Outcomes and Specific Risks

The primary life-threatening outcome documented is Acute Liver Failure (ALF), potentially requiring a liver transplant or resulting in death. Immediate medical attention is required because symptoms of severe toxicity are delayed. Increased risk of severe liver injury is noted for patients with pre-existing liver disease or those consuming three or more alcoholic drinks daily.

Mandatory Emergency Actions

Seek immediate medical help right away if an overdose is suspected, even if no symptoms are present. Prompt medical attention is critical. The specific antidote is N-acetylcysteine (NAC), used to prevent or lessen hepatic injury. Hospital monitoring and laboratory assessment of hepatic function (AST/ALT) and serum Acetaminophen concentration are required to guide management.

Advertisements

Therapeutic Uses of Мигренол

What Мигренол Treats: Main Uses and Benefits

The Acetaminophen and Caffeine combination is commonly used across conditions presenting with acute episodes characterized by symptoms related to physical discomfort and systemic imbalance. This formulation is used for symptomatic relief across various acute conditions, including headache, backache, muscular aches, and menstrual discomfort.

This analgesic combination may be part of symptomatic management for acute migraine attacks and helps address symptom clusters that may become intense or disruptive. It is applied during phases of increased distress or discomfort, often used in clinical settings that involve acute or unstable symptom patterns. This provides support that helps ease the overall symptom burden, supporting general well-being during symptomatic phases.

“The primary goal is providing supportive relief in situations where symptoms interfere with routine activities.”

Quick Fact: Relief for Acute Discomfort The combination is applied in contexts involving heightened systemic burden, offering symptomatic relief when symptoms create noticeable physiological strain.

Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Мигренол?

Мигренол (a combination product typically containing paracetamol and caffeine) is generally indicated for the relief of mild to moderate pain and migraine headaches in adults and adolescents aged 12 and older. The appropriate use and safety profile are determined by the individual components.


Contraindications

Certain individuals should not use this medication. Contraindications typically include:

  • Hypersensitivity (allergy) to paracetamol, caffeine, or any other ingredients.
  • Severe liver or kidney impairment.
  • Severe uncontrolled hypertension or significant cardiovascular disease due to the caffeine component.
  • Alcohol dependence, especially if chronic, as it increases the risk of paracetamol-related liver toxicity.
  • Glaucoma.

Specific Populations

Population Use Guidance (General)
Children under 12 Generally not recommended due to fixed-dose combination and component dosages.
Pregnancy Use should be considered only if the expected benefit outweighs the potential risk. Consultation with a healthcare provider is essential.
Breastfeeding Paracetamol and caffeine pass into breast milk; use may be permitted at therapeutic doses but requires medical advice.

Always consult a healthcare professional before starting any new medication, especially if you have pre-existing health conditions or are taking other drugs.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information outlines specific constraints regarding the concomitant use of this product with certain medicines and substances. These constraints are primarily focused on preventing additive effects from shared components and managing interactions with central nervous system depressants.

Required Constraints and Avoidance

The most stringent requirement is the absolute avoidance of co-administration with any other medicinal product containing acetaminophen. This rule is essential to prevent exceeding the recommended daily limits for the acetaminophen component, which is present in a wide range of over-the-counter and prescription products.

Specific Interacting Agents

Patients should seek the advice of a healthcare professional before combining this product with the following classes of agents:

Interaction Domain Requirement Basis
Sedatives/Tranquilizers Consult a doctor or pharmacist prior to use. Potential for additive central nervous system effects.

Other Prohibited Substances

Consumption of alcoholic drinks must be avoided during the use of this product. Official documentation requires this avoidance due to the potential for increased risk related to the acetaminophen component.

These constraints establish the product’s official interaction profile, directing patients on specific combinations that must be avoided or managed under the guidance of a healthcare professional.

Advertisements

Mechanism of Action

How Мигренол Works

Мигренол employs a multi-faceted approach to modulate activity within signaling pathways that regulate physiological excitability. It acts primarily within two distinct mechanistic domains to adjust parameters of processes that display altered nervous and vascular signaling kinetics.


alpha. Modulation of Inflammatory Mediator Production

This domain covers the enzyme-mediated signaling that influences the formation of inflammatory mediators. Мигренол modifies early molecular steps by engaging mechanisms that inhibit cyclooxygenase (COX) activity, thereby limiting the synthesis of prostaglandins. The outcome is a reduction in downstream mediator concentrations, resulting in altered setpoints within inflammatory signaling pathways.


beta. Regulation of Sensory and Vascular Signaling

This mechanism focuses on the regulation of processes driven by distinct signaling patterns in the peripheral and central nervous systems. The compound initiates signaling sequences that modulate impulse generation and transmission. It also affects systems where key transmitters or mediators dominate. The effects culminate in decreased afferent neural signaling and altered excitability within associated pathways.


gamma. Enhancement of Pathway Activity Regulation

The final component engages mechanisms that influence feedback regulation within pathways and support vascular signal processing. This is achieved by affecting receptors and systems that influence cerebral and systemic blood flow. This action results in altered setpoints of vascular tone and influences parameters governing the dynamics of vasoconstriction and vasodilation within associated systems.

Advertisements

Dosage and Administration Information

Official Administration Guidelines

Мигренол is a fixed-combination product for oral administration, typically containing acetaminophen and caffeine. It is intended for use as an acute treatment to manage a migraine attack, not for daily prevention. The official instructions emphasize proper timing and adherence to maximum dose limits to ensure patient safety and minimize the risk of medication-overuse headache.


Dosing and Administration Protocol

Administration Scope Official Regulatory Standard (Adults and Children 12+)
Route of Administration Oral (tablet)
Single Dose 2 tablets (500 mg Acetaminophen/65 mg Caffeine per tablet)
Dosing Frequency Take 2 tablets at the first sign of a migraine attack. If symptoms persist or recur, repeat the dose every 6 hours.
Maximum Daily Dose Do not take more than 8 tablets in 24 hours. The total dose of acetaminophen from all sources must not exceed 4000 mg per day.
Timing May be taken with or without food.
Missed Dose Rule Not applicable, as this is an as-needed medication taken at the onset of symptoms.
Age Restriction Not for use in children under 12 years of age.

Procedural Constraints

  • Timing of Use: Use should be initiated at the earliest sign of a migraine headache for the best chance of effectiveness.
  • Duration: Consult a healthcare professional if the condition worsens or lasts longer than 10 days. Due to the risk of medication-overuse headache, limit use to no more than 2 days per week.
  • Preparation: The tablet is swallowed whole with water; no reconstitution or dilution is required.
Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies for Мигренол

The research base for the Acetaminophen/Caffeine combination focuses on its evaluation in acute pain. Evidence comes primarily from well-designed Randomized Controlled Trials (RCTs) and comprehensive meta-analyses that explore how symptoms change over time and the measured outcomes of the combination versus placebo or the analgesic component taken alone.


Evidence for Use in Acute Migraine Attacks

Short-term, single-dose RCTs have investigated outcomes related to acute migraine headaches in adult outpatients. Studies monitored outcomes such as achieving a Pain-Free Status within two hours. Findings describe patterns where adding caffeine was often associated with a greater number of participants reporting measured pain status improvements compared to the analgesic alone. A key limitation is that many supporting studies utilized a triple combination (including aspirin), making the specific two-drug effect difficult to isolate.

Evidence for Use in Episodic Tension-Type Headache (TTH)

The evidence for TTH relies on RCTs focusing on acute symptom changes, examining discomfort and changes in headache intensity. Systematic reviews report patterns showing differences in measured outcomes for the combination relative to placebo, contributing to the broader evidence landscape for acute TTH evaluation.

Evidence on the Adjuvant Efficacy in General Acute Pain

Studies explored the adjuvant effect by monitoring pain status and the need for follow-up medication in acute pain models (e.g., post-surgical). Findings consistently associated the combination with higher measured values on discomfort scales. Research described a pattern of increased measured effect when the two compounds were co-administered, although the evidence quality varies.

What Is Still Uncertain About Мигренол Research

The existing clinical evidence is heavily focused on short-term symptom patterns. Long-term effects are not fully established because studies examining repeated, long-duration use are generally lacking. Furthermore, data for specific special populations, such as adolescent populations, remain limited.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Мигренол (FAQ)


Q: How quickly should I expect Мигренол to start working?

Official drug information describes the pharmacological properties of the active ingredients, which describes how quickly the ingredients are absorbed. This information is a general measure and does not guarantee individual experience. For best results, official instructions advise taking the medicine at the earliest sign of a migraine attack.


Q: Is it common to experience stomach upset after taking Мигренол?

Official product information indicates that gastrointestinal upset, which includes symptoms like nausea or stomach pain, is listed as a commonly reported side effect. These documents categorize side effects by how often they occurred during clinical studies.


Q: Are there any known issues with taking Мигренол and drinking coffee?

Since Мигренол contains caffeine, official warnings generally advise limiting the consumption of other caffeine-containing products, including coffee. Managing caffeine intake is part of the warning information to manage the risk of side effects associated with consuming too much caffeine, such as nervousness or difficulty sleeping.


Q: How long does the effect of Мигренол typically last?

The effect of the medication is related to the time the active ingredients remain active in the body. The dosing instructions advise that a dose may be repeated after six hours if symptoms persist or return, which provides a guideline for the expected timeframe of relief.


Q: What happens if I miss a scheduled time for Мигренол (if I were taking it regularly)?

Official administration guidelines clarify that this medicine is intended solely for acute, as-needed use, meaning it should only be taken when symptoms begin. Because it is not a daily or scheduled treatment for prevention, the rules for a missed scheduled dose are not applicable to this product.


Q: What are the ingredients in Мигренол besides the main pain reliever?

Official regulatory documents list all components of the medication. The active components are Acetaminophen and Caffeine. Labels also list the inactive ingredients, which are substances like binders or coloring agents that make up the final tablet formulation.


Q: What does the research say about long-term use of Мигренол?

Official warnings contain restrictions on the duration of use, often limiting it to no more than two days per week, due to the risk of medication-overuse headache. Research summaries also note that studies examining the effects of repeated, long-duration use are generally limited.


Q: Have there been any recent safety alerts regarding Мигренол?

Regulatory agencies continuously monitor the safety of all medications and are responsible for issuing public safety alerts or updating product labeling when new risks are identified. Users can check the public databases of governmental bodies for the most current information regarding any safety notices.


Q: Is the onset of effect the same for all individuals taking Мигренол?

While official documents describe the typical response observed in studies, factors related to individual patient characteristics, such as personal metabolism and symptom severity, can result in some variability in how quickly a person responds to any medication.


Q: Does official evidence indicate that Мигренол affects blood thinning?

Regulatory documents list specific drug interactions. Interactions with anticoagulants, which are medications known as blood thinners, are typically described due to the acetaminophen component. Official information indicates that consultation with a healthcare provider is advised when considering this product with blood thinners.


Q: Why is professional guidance sometimes needed before using Мигренол?

Consultation with a healthcare provider is often advised to screen for potential risks prior to use. This is particularly important for people with pre-existing conditions, such as severe liver or heart disease, or those who are taking other medications that may interact with the active ingredients.


Q: Are there specific food items that should be avoided while using Мигренол?

The primary substance listed for avoidance in official documents is alcoholic drinks, due to the potential risk of liver issues. Warnings also recommend limiting consumption of foods or drinks that contain significant amounts of caffeine.


Q: Are there studies comparing the results of Мигренол in different patient groups?

Clinical evidence summaries address research outcomes in specific patient populations, such as use in acute migraine attacks and tension-type headaches. Official research reports also note where data is limited, such as in adolescent populations.


Q: What happens if I take Мигренол and don't have a migraine?

The medicine is officially indicated for the relief of mild to moderate pain, including migraine and tension-type headache. Taking it when not experiencing pain or for purposes outside the official indications may expose the user to the risks and side effects associated with the active ingredients without the expected therapeutic benefit.


Q: Is it important to take Мигренол with a full glass of water?

Official administration instructions specify that the tablet should be swallowed whole with water. While some labels specify a volume, the procedural instruction is to use enough liquid to ensure the tablet is swallowed completely.


Q: How is Мигренол different from basic pain relievers like Tylenol or Advil?

Official sources describe this product as a fixed-dose combination containing two active ingredients, acetaminophen and caffeine, which work together to produce a synergistic effect. Most basic, single-ingredient pain relievers contain only one analgesic compound.


Q: What kind of studies have been done on the use of Мигренол?

The research base for the combination product includes well-designed Randomized Controlled Trials (RCTs) and meta-analyses. These studies focus on short-term outcomes such as achieving pain-free status in acute pain and various headache types.


Q: Does the official guidance for Мигренол mention anything about liver health?

Official guidance contains serious warnings about potential liver damage related to the acetaminophen component, especially if the maximum daily dose is exceeded or if taken with alcohol. Severe liver impairment is also listed as a contraindication for using the product.


Q: Can Мигренол interact with blood pressure medication?

Due to the caffeine component, severe uncontrolled hypertension or significant cardiovascular disease is listed as a contraindication. This means that individuals using medication for blood pressure are advised to consult with a healthcare professional, as the drug may potentially affect blood pressure.


Q: Why do some people say they take Мигренол for more than just a headache?

Official regulatory documents indicate that the product is intended for the symptomatic relief of pain and fever. This use extends beyond migraine headaches to include the management of general mild to moderate pain and tension-type headaches.


Q: Is it better to take Мигренол at the very start of a migraine?

Official administration instructions state that the use of this medicine should be initiated at the earliest sign of a migraine headache. This procedural constraint is described as being associated with optimal effectiveness.


Q: Does food change the way Мигренол works in the body?

Official regulatory administration guidelines state that the medicine may be taken with or without food. This instruction relates to the convenience of administration rather than a requirement for the drug to work properly.


Q: Are there warnings about taking Мигренол with antidepressants?

Official warnings specifically list the avoidance of co-administration with MAO inhibitors, which are one class of medication sometimes used as antidepressants. For all other types of antidepressants, official guidance suggests seeking consultation with a healthcare provider.


Q: What is the role of the ingredients in Мигренол working together?

Official sources describe the role of the ingredients as dual-action. Acetaminophen provides the primary pain-modulating effect, and caffeine acts as an adjuvant to enhance the overall pain-relieving efficacy, resulting in a documented synergistic effect.


Q: Is there a specific mechanism described for how Мигренол relieves pain?

The described mechanism of action involves multiple pathways. It includes components that help inhibit the synthesis of inflammatory mediators and affect signaling patterns in the nervous system to decrease afferent neural signaling.

Advertisements

How should Мигренол be stored and disposed of?

How to Store and Dispose of Мигренол?

Official regulatory guidelines for this multi-ingredient analgesic generally require storage at Controlled Room Temperature, defined as 20°C to 25°C (68°F to 77°F).

Storage Requirements

Condition Regulatory Standard
Temperature Store between 20°C and 25°C.
Container Keep in the original container with the cap tightly closed to protect from moisture.
Safety Store out of the sight and reach of children and pets, using a child-resistant cap.

Disposal Instructions

Do not flush unused or expired medicine down the toilet or pour it down the drain. The preferred method of disposal is using an official drug take-back program or mail-back envelope. If those options are not available, the medication should be mixed with an unappealing substance (such as dirt or coffee grounds), sealed in a plastic bag, and placed in the household trash. Always check the expiration date and dispose of expired product immediately.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Мигренол found in:

A-Z Index: